Researchers from Monash University's Turner Institute for Brain and Mental Health have developed a mobile app that helps personalise the sleep-wake cycle of hospital shift workers.
HOW IT WORKS
The app called SleepSync entirely tailors a sleep-wake cycle to an individual user by taking into account their calendar for work and personal commitments and daily logging of actual sleep/wake times and...
Another digital therapeutics app for treating insomnia has been approved by the South Korean Ministry of Food and Drug Safety.
The mobile app called WELT-I by Welt Co. is the second insomnia DTx to be approved in the country.
WHAT IT DOES
WELT-I uses cognitive behavioural therapy (CBT), which is the first-line treatment for insomnia, to address the underlying causes of chronic insomnia.
It is a...
San Diego-based medical device company ResMed has announced the acquisition of mementor, a consumer software developer that offers a digital solution for insomnia.
The financial terms of the transaction were not disclosed.
The acquisition of Leipzig, Germany-based mementor lays the foundation for ResMed to build its digital sleep medicine portfolio in Germany, the company said. The deal was...
The National Institute for Health and Care Excellence (NICE) has recommended the Sleepio app as an effective alternative to sleeping pills.
In its guidance, NICE states the app, created by digital therapeutics (DTx) firm Big Health, is a safe and effective treatment for people suffering from insomnia.
It adds that the app could save the NHS money and reduce prescriptions of medicines such as...
Digital cognitive behavioral therapy could help treat Black women with insomnia, according to a new study published in JAMA.
Researchers found that study participants using an internet-based intervention for insomnia, with a tailored version for Black women and a standard version, significantly reduced their score on the insomnia severity index.
In the single-blind, 3-arm randomized control...
Using Sleepio, a digital therapeutic to reduce insomnia, improved sleep, anxiety and depression more than other psychological interventions alone, according to a study published in Behaviour Research and Therapy.
The study was partially funded by Big Health, Sleepio’s parent company, and most authors were Big Health employees or paid consultants.
TOP-LINE DATA
Patients who used Sleepio achieved...
There is a dearth of published literature regarding the design, implementation and evaluation of mobile apps for sleep disturbance, as well as little indication of any standardized best practices adopted by sleep app developers or evaluators, according to a systematic review published yesterday in JMIR.
The shortage of available data within this space is concerning in light of the 500-plus sleep...
A recent mathematical simulation model found that, compared to other insomnia interventions like group cognitive behavioral therapy or pharmacotherapy, digital CBT delivered via Big Health's Sleepio was more cost-effective due to lower expenditures.
The research was funded by Big Health, and conducted by researchers from Johns Hopkins, the University of California, San Francisco, and the digital...
Pear Therapeutics highlighted data today from two studies of a digital cognitive behavioral therapy that acted as the precursor for Somryst, the prescription digital therapeutic for adults with chronic insomnia that was the first to pass through the FDA's Pre-Cert pilot pathway.
The first, a randomized controlled trial of 1,149 Australian adults with insomnia and depressive symptoms, suggested...
The use of cognitive-behavioral therapy interventions, such as Big Health’s Sleepio program, has been found to improve both sleep and mental health in individuals with insomnia and clinically significant depressive symptoms, according to new research published in the Journal of Sleep Research.
Sleepio is a digital sleep-improvement program that offers personalized treatment base on a user’s...
